EyePoint Pharmaceuticals, Inc. (FRA:PV3B)

EyePoint Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,016	505	984	112	365	81
Market Cap Growth	38.23%	-48.70%	781.75%	-69.40%	348.21%	-45.50%
Enterprise Value	860	282	867	8	294	102
Last Close Price	12.29	6.68	21.20	3.22	11.10	4.41
PS Ratio	28.14	12.08	23.64	2.88	11.23	2.89
PB Ratio	5.95	1.55	4.09	1.24	2.25	5.37
P/TBV Ratio	5.95	1.55	4.09	1.24	2.57	-
P/OCF Ratio	-	-	580.20	-	-	-
EV/Sales Ratio	23.61	6.75	20.82	0.21	9.05	3.62
EV/FCF Ratio	-4.72	-	-	-	-	-
Debt / Equity Ratio	0.12	0.07	0.02	0.48	0.21	2.22
Asset Turnover	0.15	0.11	0.17	0.19	0.21	0.42
Inventory Turnover	82.88	43.12	20.06	17.83	8.06	6.22
Quick Ratio	6.81	7.58	5.25	4.64	9.72	3.65
Current Ratio	7.18	7.82	5.45	5.00	10.05	4.24
Return on Equity (ROE)	-98.23%	-43.42%	-39.04%	-72.84%	-57.58%	-337.87%
Return on Assets (ROA)	-49.38%	-23.57%	-17.52%	-22.24%	-19.46%	-28.30%
Return on Capital (ROIC)	-58.65%	-28.88%	-22.64%	-26.94%	-24.40%	-39.32%
Return on Capital Employed (ROCE)	-98.50%	-39.50%	-25.70%	-54.10%	-23.10%	-48.50%
Earnings Yield	-17.27%	-25.04%	-6.51%	-85.72%	-14.08%	-45.60%
FCF Yield	-17.93%	-24.92%	-0.15%	-56.29%	-12.11%	-14.86%
Buyback Yield / Dilution	-35.36%	-44.71%	-4.25%	-29.76%	-124.04%	-23.06%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.